Loading…
Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation
Mineralocorticoids have been implicated in promoting fibrous tissue formation in various organs. In the present study, we sought to address the potential contribution of mineralocorticoids to fibrous tissue formation using a skin pouch model which has proved valuable for the analysis of inflammatory...
Saved in:
| Published in: | Molecular and cellular biochemistry 1998-12, Vol.189 (1-2), p.47-54 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c279t-438bbd4f8a8ff15094786286a6b2f77da31000191fd85e841c39323a5cd19c393 |
|---|---|
| cites | |
| container_end_page | 54 |
| container_issue | 1-2 |
| container_start_page | 47 |
| container_title | Molecular and cellular biochemistry |
| container_volume | 189 |
| creator | Slight, S H Chilakamarri, V K Nasr, S Dhalla, A K Ramires, F J Sun, Y Ganjam, V K Weber, K T |
| description | Mineralocorticoids have been implicated in promoting fibrous tissue formation in various organs. In the present study, we sought to address the potential contribution of mineralocorticoids to fibrous tissue formation using a skin pouch model which has proved valuable for the analysis of inflammatory and wound healing responses. Skin pouches were induced in rats by administration of a phorbol ester, croton oil (0.5 ml of a 1% solution). After 2 weeks, rats were killed and intact pouch tissue collected. Pouch weights of control and aldosterone-treated (0.75 microg/h via osmotic minipump) rats were similar (3.33 +/- 0.44 g vs. 3.70 +/- 0.28 g respectively). However, pouch weights were reduced by more than 50% in spironolactone-treated (25 mg/day powdered in food) animals (1.62 +/- 0.22 g and 1.27 +/- 0.23 g respectively in aldosterone and spironolactone alone groups). To ascertain the effects of different treatments on collagen accumulation, hydroxyproline concentration was measured. Compared with controls, hydroxyproline concentration was significantly reduced following spironolactone treatment (17.1 +/- 0.08 vs. 7.5 +/- 2.0 microg/mg dry wt, respectively, p < 0.01). This response to spironolactone was negated by coadministration of aldosterone (hydroxyproline concentration was 18.6 +/- 2.1 microg/mg dry wt). Following bilateral adrenalectomy, spironolactone reduced pouch weight and hydroxyproline concentration, which was not the case for adrenalectomy alone. Two week aldosterone administration in uninephrectomized rats on high salt diet was deemed ineffective in modulating pouch development (pouch wet wts were 3.48 +/- 0.4 g vs. 3.00 +/- 0.19 g in controls and aldosterone-treated rats, respectively). Mineralocorticoid receptor expression in pouch tissue was demonstrated by RT/PCR. Furthermore, NADP+-dependent 11beta-hydroxysteroid dehydrogenase 1 (11beta-HSD1) activity was detected in pouch tissue, together with lower levels of NAD+-dependent 11beta-HSD2. Spironolactone (p < 0.05) significantly reduced 11beta-HSD1 activity compared with controls. Thus, fibrous tissue possesses requisite components of MC action, and antagonism of mineralocorticoid receptors by spironolactone attenuates its formation. Pouch formation is under the influence of circulating MC and, we would like to propose, is also mediated through corticosteroids generated de novo at the site of tissue repair. |
| doi_str_mv | 10.1023/a:1006844010371 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69117111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69117111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-438bbd4f8a8ff15094786286a6b2f77da31000191fd85e841c39323a5cd19c393</originalsourceid><addsrcrecordid>eNpdkDtPwzAURi0EKqUwMyFZDGwBX9vxoxuqeFSqxAJz5CS2cJXYwU4G_j2pKAvT_Yajo6OL0DWQeyCUPZg1ECIU5wQIk3CCllBKVnAN-hQtCSOkUCDlObrIeU9miAAs0EIrqUXJlshuw6ev_ehjwNHh0ec8WZzsYHzC9TfOg08xxM40Ywx2jVPs7AHsfbDJdLGJafRN9G3GPmDn6xSn_KdxMfXmoL5EZ8502V4d7wp9PD-9b16L3dvLdvO4Kxoq9Vhwpuq65U4Z5RyURHOpBFXCiJo6KVvD5n4CGlyrSqs4NEwzykzZtKAPe4Xufr1Dil-TzWPV-9zYrjPBzl2V0AASAGbw9h-4j1MKc1slS0FLIjSdoZsjNNW9bash-d6k7-r4PPYD_yZxfQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756250692</pqid></control><display><type>article</type><title>Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation</title><source>Springer Link</source><creator>Slight, S H ; Chilakamarri, V K ; Nasr, S ; Dhalla, A K ; Ramires, F J ; Sun, Y ; Ganjam, V K ; Weber, K T</creator><creatorcontrib>Slight, S H ; Chilakamarri, V K ; Nasr, S ; Dhalla, A K ; Ramires, F J ; Sun, Y ; Ganjam, V K ; Weber, K T</creatorcontrib><description>Mineralocorticoids have been implicated in promoting fibrous tissue formation in various organs. In the present study, we sought to address the potential contribution of mineralocorticoids to fibrous tissue formation using a skin pouch model which has proved valuable for the analysis of inflammatory and wound healing responses. Skin pouches were induced in rats by administration of a phorbol ester, croton oil (0.5 ml of a 1% solution). After 2 weeks, rats were killed and intact pouch tissue collected. Pouch weights of control and aldosterone-treated (0.75 microg/h via osmotic minipump) rats were similar (3.33 +/- 0.44 g vs. 3.70 +/- 0.28 g respectively). However, pouch weights were reduced by more than 50% in spironolactone-treated (25 mg/day powdered in food) animals (1.62 +/- 0.22 g and 1.27 +/- 0.23 g respectively in aldosterone and spironolactone alone groups). To ascertain the effects of different treatments on collagen accumulation, hydroxyproline concentration was measured. Compared with controls, hydroxyproline concentration was significantly reduced following spironolactone treatment (17.1 +/- 0.08 vs. 7.5 +/- 2.0 microg/mg dry wt, respectively, p < 0.01). This response to spironolactone was negated by coadministration of aldosterone (hydroxyproline concentration was 18.6 +/- 2.1 microg/mg dry wt). Following bilateral adrenalectomy, spironolactone reduced pouch weight and hydroxyproline concentration, which was not the case for adrenalectomy alone. Two week aldosterone administration in uninephrectomized rats on high salt diet was deemed ineffective in modulating pouch development (pouch wet wts were 3.48 +/- 0.4 g vs. 3.00 +/- 0.19 g in controls and aldosterone-treated rats, respectively). Mineralocorticoid receptor expression in pouch tissue was demonstrated by RT/PCR. Furthermore, NADP+-dependent 11beta-hydroxysteroid dehydrogenase 1 (11beta-HSD1) activity was detected in pouch tissue, together with lower levels of NAD+-dependent 11beta-HSD2. Spironolactone (p < 0.05) significantly reduced 11beta-HSD1 activity compared with controls. Thus, fibrous tissue possesses requisite components of MC action, and antagonism of mineralocorticoid receptors by spironolactone attenuates its formation. Pouch formation is under the influence of circulating MC and, we would like to propose, is also mediated through corticosteroids generated de novo at the site of tissue repair.</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1023/a:1006844010371</identifier><identifier>PMID: 9879653</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>11-beta-Hydroxysteroid Dehydrogenases ; Adrenalectomy ; Aldosterone - physiology ; Animals ; Diet ; Gene Expression ; Granulation Tissue - metabolism ; Hydroxyproline - metabolism ; Hydroxyproline - physiology ; Hydroxysteroid Dehydrogenases - genetics ; Hydroxysteroid Dehydrogenases - metabolism ; Male ; Mineralocorticoids - physiology ; Models, Biological ; Rats ; Rats, Sprague-Dawley ; Rodents ; Sodium Chloride - pharmacology ; Spironolactone - pharmacology ; Wound healing ; Wound Healing - physiology</subject><ispartof>Molecular and cellular biochemistry, 1998-12, Vol.189 (1-2), p.47-54</ispartof><rights>Kluwer Academic Publishers 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c279t-438bbd4f8a8ff15094786286a6b2f77da31000191fd85e841c39323a5cd19c393</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9879653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Slight, S H</creatorcontrib><creatorcontrib>Chilakamarri, V K</creatorcontrib><creatorcontrib>Nasr, S</creatorcontrib><creatorcontrib>Dhalla, A K</creatorcontrib><creatorcontrib>Ramires, F J</creatorcontrib><creatorcontrib>Sun, Y</creatorcontrib><creatorcontrib>Ganjam, V K</creatorcontrib><creatorcontrib>Weber, K T</creatorcontrib><title>Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation</title><title>Molecular and cellular biochemistry</title><addtitle>Mol Cell Biochem</addtitle><description>Mineralocorticoids have been implicated in promoting fibrous tissue formation in various organs. In the present study, we sought to address the potential contribution of mineralocorticoids to fibrous tissue formation using a skin pouch model which has proved valuable for the analysis of inflammatory and wound healing responses. Skin pouches were induced in rats by administration of a phorbol ester, croton oil (0.5 ml of a 1% solution). After 2 weeks, rats were killed and intact pouch tissue collected. Pouch weights of control and aldosterone-treated (0.75 microg/h via osmotic minipump) rats were similar (3.33 +/- 0.44 g vs. 3.70 +/- 0.28 g respectively). However, pouch weights were reduced by more than 50% in spironolactone-treated (25 mg/day powdered in food) animals (1.62 +/- 0.22 g and 1.27 +/- 0.23 g respectively in aldosterone and spironolactone alone groups). To ascertain the effects of different treatments on collagen accumulation, hydroxyproline concentration was measured. Compared with controls, hydroxyproline concentration was significantly reduced following spironolactone treatment (17.1 +/- 0.08 vs. 7.5 +/- 2.0 microg/mg dry wt, respectively, p < 0.01). This response to spironolactone was negated by coadministration of aldosterone (hydroxyproline concentration was 18.6 +/- 2.1 microg/mg dry wt). Following bilateral adrenalectomy, spironolactone reduced pouch weight and hydroxyproline concentration, which was not the case for adrenalectomy alone. Two week aldosterone administration in uninephrectomized rats on high salt diet was deemed ineffective in modulating pouch development (pouch wet wts were 3.48 +/- 0.4 g vs. 3.00 +/- 0.19 g in controls and aldosterone-treated rats, respectively). Mineralocorticoid receptor expression in pouch tissue was demonstrated by RT/PCR. Furthermore, NADP+-dependent 11beta-hydroxysteroid dehydrogenase 1 (11beta-HSD1) activity was detected in pouch tissue, together with lower levels of NAD+-dependent 11beta-HSD2. Spironolactone (p < 0.05) significantly reduced 11beta-HSD1 activity compared with controls. Thus, fibrous tissue possesses requisite components of MC action, and antagonism of mineralocorticoid receptors by spironolactone attenuates its formation. Pouch formation is under the influence of circulating MC and, we would like to propose, is also mediated through corticosteroids generated de novo at the site of tissue repair.</description><subject>11-beta-Hydroxysteroid Dehydrogenases</subject><subject>Adrenalectomy</subject><subject>Aldosterone - physiology</subject><subject>Animals</subject><subject>Diet</subject><subject>Gene Expression</subject><subject>Granulation Tissue - metabolism</subject><subject>Hydroxyproline - metabolism</subject><subject>Hydroxyproline - physiology</subject><subject>Hydroxysteroid Dehydrogenases - genetics</subject><subject>Hydroxysteroid Dehydrogenases - metabolism</subject><subject>Male</subject><subject>Mineralocorticoids - physiology</subject><subject>Models, Biological</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rodents</subject><subject>Sodium Chloride - pharmacology</subject><subject>Spironolactone - pharmacology</subject><subject>Wound healing</subject><subject>Wound Healing - physiology</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNpdkDtPwzAURi0EKqUwMyFZDGwBX9vxoxuqeFSqxAJz5CS2cJXYwU4G_j2pKAvT_Yajo6OL0DWQeyCUPZg1ECIU5wQIk3CCllBKVnAN-hQtCSOkUCDlObrIeU9miAAs0EIrqUXJlshuw6ev_ehjwNHh0ec8WZzsYHzC9TfOg08xxM40Ywx2jVPs7AHsfbDJdLGJafRN9G3GPmDn6xSn_KdxMfXmoL5EZ8502V4d7wp9PD-9b16L3dvLdvO4Kxoq9Vhwpuq65U4Z5RyURHOpBFXCiJo6KVvD5n4CGlyrSqs4NEwzykzZtKAPe4Xufr1Dil-TzWPV-9zYrjPBzl2V0AASAGbw9h-4j1MKc1slS0FLIjSdoZsjNNW9bash-d6k7-r4PPYD_yZxfQ</recordid><startdate>19981201</startdate><enddate>19981201</enddate><creator>Slight, S H</creator><creator>Chilakamarri, V K</creator><creator>Nasr, S</creator><creator>Dhalla, A K</creator><creator>Ramires, F J</creator><creator>Sun, Y</creator><creator>Ganjam, V K</creator><creator>Weber, K T</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>19981201</creationdate><title>Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation</title><author>Slight, S H ; Chilakamarri, V K ; Nasr, S ; Dhalla, A K ; Ramires, F J ; Sun, Y ; Ganjam, V K ; Weber, K T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-438bbd4f8a8ff15094786286a6b2f77da31000191fd85e841c39323a5cd19c393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>11-beta-Hydroxysteroid Dehydrogenases</topic><topic>Adrenalectomy</topic><topic>Aldosterone - physiology</topic><topic>Animals</topic><topic>Diet</topic><topic>Gene Expression</topic><topic>Granulation Tissue - metabolism</topic><topic>Hydroxyproline - metabolism</topic><topic>Hydroxyproline - physiology</topic><topic>Hydroxysteroid Dehydrogenases - genetics</topic><topic>Hydroxysteroid Dehydrogenases - metabolism</topic><topic>Male</topic><topic>Mineralocorticoids - physiology</topic><topic>Models, Biological</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rodents</topic><topic>Sodium Chloride - pharmacology</topic><topic>Spironolactone - pharmacology</topic><topic>Wound healing</topic><topic>Wound Healing - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Slight, S H</creatorcontrib><creatorcontrib>Chilakamarri, V K</creatorcontrib><creatorcontrib>Nasr, S</creatorcontrib><creatorcontrib>Dhalla, A K</creatorcontrib><creatorcontrib>Ramires, F J</creatorcontrib><creatorcontrib>Sun, Y</creatorcontrib><creatorcontrib>Ganjam, V K</creatorcontrib><creatorcontrib>Weber, K T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database (ProQuest)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Slight, S H</au><au>Chilakamarri, V K</au><au>Nasr, S</au><au>Dhalla, A K</au><au>Ramires, F J</au><au>Sun, Y</au><au>Ganjam, V K</au><au>Weber, K T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation</atitle><jtitle>Molecular and cellular biochemistry</jtitle><addtitle>Mol Cell Biochem</addtitle><date>1998-12-01</date><risdate>1998</risdate><volume>189</volume><issue>1-2</issue><spage>47</spage><epage>54</epage><pages>47-54</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Mineralocorticoids have been implicated in promoting fibrous tissue formation in various organs. In the present study, we sought to address the potential contribution of mineralocorticoids to fibrous tissue formation using a skin pouch model which has proved valuable for the analysis of inflammatory and wound healing responses. Skin pouches were induced in rats by administration of a phorbol ester, croton oil (0.5 ml of a 1% solution). After 2 weeks, rats were killed and intact pouch tissue collected. Pouch weights of control and aldosterone-treated (0.75 microg/h via osmotic minipump) rats were similar (3.33 +/- 0.44 g vs. 3.70 +/- 0.28 g respectively). However, pouch weights were reduced by more than 50% in spironolactone-treated (25 mg/day powdered in food) animals (1.62 +/- 0.22 g and 1.27 +/- 0.23 g respectively in aldosterone and spironolactone alone groups). To ascertain the effects of different treatments on collagen accumulation, hydroxyproline concentration was measured. Compared with controls, hydroxyproline concentration was significantly reduced following spironolactone treatment (17.1 +/- 0.08 vs. 7.5 +/- 2.0 microg/mg dry wt, respectively, p < 0.01). This response to spironolactone was negated by coadministration of aldosterone (hydroxyproline concentration was 18.6 +/- 2.1 microg/mg dry wt). Following bilateral adrenalectomy, spironolactone reduced pouch weight and hydroxyproline concentration, which was not the case for adrenalectomy alone. Two week aldosterone administration in uninephrectomized rats on high salt diet was deemed ineffective in modulating pouch development (pouch wet wts were 3.48 +/- 0.4 g vs. 3.00 +/- 0.19 g in controls and aldosterone-treated rats, respectively). Mineralocorticoid receptor expression in pouch tissue was demonstrated by RT/PCR. Furthermore, NADP+-dependent 11beta-hydroxysteroid dehydrogenase 1 (11beta-HSD1) activity was detected in pouch tissue, together with lower levels of NAD+-dependent 11beta-HSD2. Spironolactone (p < 0.05) significantly reduced 11beta-HSD1 activity compared with controls. Thus, fibrous tissue possesses requisite components of MC action, and antagonism of mineralocorticoid receptors by spironolactone attenuates its formation. Pouch formation is under the influence of circulating MC and, we would like to propose, is also mediated through corticosteroids generated de novo at the site of tissue repair.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>9879653</pmid><doi>10.1023/a:1006844010371</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-8177 |
| ispartof | Molecular and cellular biochemistry, 1998-12, Vol.189 (1-2), p.47-54 |
| issn | 0300-8177 1573-4919 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69117111 |
| source | Springer Link |
| subjects | 11-beta-Hydroxysteroid Dehydrogenases Adrenalectomy Aldosterone - physiology Animals Diet Gene Expression Granulation Tissue - metabolism Hydroxyproline - metabolism Hydroxyproline - physiology Hydroxysteroid Dehydrogenases - genetics Hydroxysteroid Dehydrogenases - metabolism Male Mineralocorticoids - physiology Models, Biological Rats Rats, Sprague-Dawley Rodents Sodium Chloride - pharmacology Spironolactone - pharmacology Wound healing Wound Healing - physiology |
| title | Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T08%3A33%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20tissue%20repair%20by%20spironolactone:%20role%20of%20mineralocorticoids%20in%20fibrous%20tissue%20formation&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Slight,%20S%20H&rft.date=1998-12-01&rft.volume=189&rft.issue=1-2&rft.spage=47&rft.epage=54&rft.pages=47-54&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1023/a:1006844010371&rft_dat=%3Cproquest_pubme%3E69117111%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c279t-438bbd4f8a8ff15094786286a6b2f77da31000191fd85e841c39323a5cd19c393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=756250692&rft_id=info:pmid/9879653&rfr_iscdi=true |